Drotin (Spironolactone) Contraindicated in Pregnancy: Fetal Risks in Second/Third Trimester
Drotin (brand name for spironolactone), a potassium-sparing diuretic, is contraindicated in pregnancy, especially second and third trimesters. Fetal/neonatal adverse effects include hypokalemia with hypovolemia, hypotension, azotemia, renal tubule dysgenesis leading to childhood renal impairment.
Pregnancy & Health - Related Articles
- Birth Without Ruptured Membranes: Causes, Risks & What to Expect
- Short‑Term Disability and Pregnancy: Understanding Benefit Eligibility
- Pregnancy Warning Signs: Yellow Discharge, Itching & Reduced Fetal Movement
- No Yolk Sac at 5 Weeks Pregnancy: Is It Normal? Next Steps for Viability Assessment
- Bloating as an Ectopic Pregnancy Symptom: Know the Warning Signs
- 5 Weeks Pregnant: Ultrasound Findings and Bleeding Concerns
- Natural Labor Induction at 38 Weeks: Safe Methods & Considerations
